Economic portfolio
Nippon India Nifty Pharma ETF
NIPPON Nippon India Mutual Fund Feb 2022 — Sep 2026 55 months
Data periodFund holdingsSep 2026NSE prices23 Oct 2026Data status →
Days to sell half: 2.3 — selling half of every holding at 20% of each stock’s usual daily NSE trading, the time to get through 90% of the portfolio (Sep 2026). Quick to unwind on normal volumes. Small-cap comparison →
Shares of this fund’s disclosed Indian listed equity, valued at official NSE closing prices. Cash, debt, derivatives and overseas holdings are not included, so for a hybrid or debt fund these are shares of its equity part only. Not performance, and not a recommendation.
How concentrated it has been
55 priced months, Feb 2022 to Sep 2026 · at each month’s NSE closes
Top 10 holdings, share of equity
78.2% now, 78.0% in Sep 2025 · highest 83.0%, lowest 78.0%
Companies held
20 now, 20 in Sep 2025 · largest single holding 19.5% of equity
How it trades: no clear lean toward recent winners or losers (score -0.04 over 47 months; −1 always buys the biggest fallers, +1 the biggest risers, 0 no pattern). Value and contra funds average −0.10, other active funds about 0. A description of behaviour, not of results. How this was tested →
Sector mix
Share of the equity shown · NSE industry
Funds most like this one
Overlap of disclosed equity · the smaller share of each company both hold, added up
- ICICI Prudential Nifty Pharma Index FundICICI Prudential · 20 shared100.0%
- ICICI Prudential Nifty Healthcare ETFICICI Prudential · 16 shared81.1%
- DSP Nifty Healthcare ETFDSP · 16 shared81.1%
- Axis NIFTY Healthcare ETFAxis · 16 shared81.1%
- DSP Nifty Healthcare Index FundDSP · 16 shared81.1%
- ADITYA BIRLA SUN LIFE NIFTY HEALTHCARE ETFAditya Birla Sun Life · 16 shared81.1%
- EODWHFEdelweiss · 17 shared77.4%
- Mirae Asset Nifty 500 Healthcare ETFMirae Asset · 20 shared69.0%
Select one to see exactly what the two funds share. Index funds and ETFs tracking the same index overlap almost completely.
What changed in Sep 2026
This portfolio’s consecutive disclosures · evidenced adjustments applied
New positions
- None this month.
Complete exits
- None this month.
Largest increases
- 01 Sun Pharmaceutical Industries Limited+1.3% +23,565
- 02 Dr. Reddy's Laboratories Limited+1.3% +14,091
- 03 Cipla Limited+1.3% +12,685
- 04 Piramal Pharma Limited+1.2% +12,478
- 05 Laurus Labs Limited+1.4% +9,367
- 06 Ajanta Pharma Limited+9.6% +7,039
- 07 Lupin Limited+1.3% +5,525
- 08 Aurobindo Pharma Limited+1.1% +5,426
- 09 Alkem Laboratories Limited+4.4% +4,432
- 10 Torrent Pharmaceuticals Limited+1.6% +4,105
Largest reductions
Share quantities, not market values or cash flows.
Holdings by value
Sep 2026 · largest 100 · share of the equity shown
| Company | Sector | Size | Share of equity | Value | Shares held | Held since |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Limited | Healthcare | Large Cap | 19.51% | 339 Cr | 0.19 Cr | by Feb 2022 (55 mo+) |
| Divi's Laboratories Limited | Healthcare | Large Cap | 11.98% | 208 Cr | 0.02 Cr | by Feb 2022 (55 mo+) |
| Laurus Labs Limited | Healthcare | Mid Cap | 7.82% | 136 Cr | 0.07 Cr | by Feb 2022 (55 mo+) |
| Cipla Limited | Healthcare | Large Cap | 7.68% | 133 Cr | 0.10 Cr | by Feb 2022 (55 mo+) |
| Dr. Reddy's Laboratories Limited | Healthcare | Large Cap | 7.63% | 132 Cr | 0.11 Cr | by Feb 2022 (55 mo+) |
| Torrent Pharmaceuticals Limited | Healthcare | Large Cap | 7.16% | 124 Cr | 0.03 Cr | by Feb 2022 (55 mo+) |
| Lupin Limited | Healthcare | Mid Cap | 5.00% | 86.83 Cr | 0.04 Cr | by Feb 2022 (55 mo+) |
| Aurobindo Pharma Limited | Healthcare | Mid Cap | 4.69% | 81.36 Cr | 0.05 Cr | by Feb 2022 (55 mo+) |
| Glenmark Pharmaceuticals Limited | Healthcare | Mid Cap | 3.57% | 61.89 Cr | 0.03 Cr | by Feb 2022 (55 mo+) |
| Alkem Laboratories Limited | Healthcare | Mid Cap | 3.16% | 54.82 Cr | 0.01 Cr | by Feb 2022 (55 mo+) |
| Zydus Lifesciences Limited | Healthcare | Mid Cap | 2.92% | 50.70 Cr | 0.04 Cr | by Feb 2022 (55 mo+) |
| Mankind Pharma Limited | Healthcare | Mid Cap | 2.88% | 49.96 Cr | 0.02 Cr | Mar 2024 (30 mo) |
| IPCA Laboratories Limited | Healthcare | Mid Cap | 2.72% | 47.14 Cr | 0.02 Cr | by Feb 2022 (55 mo+) |
| Biocon Limited | Healthcare | Mid Cap | 2.62% | 45.44 Cr | 0.12 Cr | by Feb 2022 (55 mo+) |
| Gland Pharma Limited | Healthcare | Small Cap | 2.34% | 40.69 Cr | 0.01 Cr | by Feb 2022 (55 mo+) |
| Sai Life Sciences Limited | Healthcare | Small Cap | 2.14% | 37.13 Cr | 0.02 Cr | Jul 2026 (3 mo) |
| Wockhardt Limited | Healthcare | Small Cap | 1.77% | 30.78 Cr | 0.01 Cr | Sep 2025 (13 mo) |
| Ajanta Pharma Limited | Healthcare | Small Cap | 1.67% | 29.06 Cr | 80,268 | Sep 2024 (25 mo) |
| Abbott India Limited | Healthcare | Mid Cap | 1.43% | 24.89 Cr | 9,176 | by Feb 2022 (55 mo+) |
| Piramal Pharma Limited | Healthcare | Small Cap | 1.30% | 22.59 Cr | 0.11 Cr | Sep 2025 (13 mo) |
Half of its current holdings have been held for 55 disclosed months or more without a break. “By” means held in the first month we have for this fund, so possibly for longer. Counted over this fund’s own monthly disclosures; a merger (e.g. HDFC into HDFC Bank, July 2023) starts a new run for the surviving company.
Recent position changes
Latest 100 company-month records · evidenced adjustments applied
| Company | Month | Activity | Adjusted change |
|---|---|---|---|
| Sun Pharmaceutical Industries Limited | Sep 2026 | ▲ Increasing | +23,565 |
| Dr. Reddy's Laboratories Limited | Sep 2026 | ▲ Increasing | +14,091 |
| Biocon Limited | Sep 2026 | ▼ Reducing | -13,184 |
| Cipla Limited | Sep 2026 | ▲ Increasing | +12,685 |
| Piramal Pharma Limited | Sep 2026 | ▲ Increasing | +12,478 |
| Laurus Labs Limited | Sep 2026 | ▲ Increasing | +9,367 |
| Ajanta Pharma Limited | Sep 2026 | ▲ Increasing | +7,039 |
| Lupin Limited | Sep 2026 | ▲ Increasing | +5,525 |
| Aurobindo Pharma Limited | Sep 2026 | ▲ Increasing | +5,426 |
| Alkem Laboratories Limited | Sep 2026 | ▲ Increasing | +4,432 |
| Torrent Pharmaceuticals Limited | Sep 2026 | ▲ Increasing | +4,105 |
| Sai Life Sciences Limited | Sep 2026 | ▲ Increasing | +3,671 |
| Glenmark Pharmaceuticals Limited | Sep 2026 | ▲ Increasing | +3,356 |
| IPCA Laboratories Limited | Sep 2026 | ▲ Increasing | +3,133 |
| Divi's Laboratories Limited | Sep 2026 | ▲ Increasing | +2,839 |
| Mankind Pharma Limited | Sep 2026 | ▲ Increasing | +2,731 |
| Wockhardt Limited | Sep 2026 | ▲ Increasing | +1,890 |
| Gland Pharma Limited | Sep 2026 | ▲ Increasing | +1,810 |
| Zydus Lifesciences Limited | Sep 2026 | ▲ Increasing | +1,378 |
| Abbott India Limited | Sep 2026 | ▲ Increasing | +121 |
| Sun Pharmaceutical Industries Limited | Aug 2026 | ▲ Increasing | +31,424 |
| Biocon Limited | Aug 2026 | ▲ Increasing | +21,177 |
| Piramal Pharma Limited | Aug 2026 | ▲ Increasing | +18,485 |
| Dr. Reddy's Laboratories Limited | Aug 2026 | ▲ Increasing | +18,084 |
| Cipla Limited | Aug 2026 | ▲ Increasing | +16,687 |
| Laurus Labs Limited | Aug 2026 | ▲ Increasing | +11,543 |
| Aurobindo Pharma Limited | Aug 2026 | ▲ Increasing | +8,196 |
| Zydus Lifesciences Limited | Aug 2026 | ▲ Increasing | +7,444 |
| Lupin Limited | Aug 2026 | ▲ Increasing | +7,190 |
| Glenmark Pharmaceuticals Limited | Aug 2026 | ▲ Increasing | +4,458 |
| Torrent Pharmaceuticals Limited | Aug 2026 | ▲ Increasing | +4,371 |
| IPCA Laboratories Limited | Aug 2026 | ▲ Increasing | +4,142 |
| Sai Life Sciences Limited | Aug 2026 | ▲ Increasing | +4,129 |
| Divi's Laboratories Limited | Aug 2026 | ▲ Increasing | +3,766 |
| Mankind Pharma Limited | Aug 2026 | ▲ Increasing | +3,329 |
| Wockhardt Limited | Aug 2026 | ▲ Increasing | +2,445 |
| Gland Pharma Limited | Aug 2026 | ▲ Increasing | +2,345 |
| Alkem Laboratories Limited | Aug 2026 | ▲ Increasing | +1,745 |
| Ajanta Pharma Limited | Aug 2026 | ▲ Increasing | +1,314 |
| Abbott India Limited | Aug 2026 | ▲ Increasing | +149 |
| Sai Life Sciences Limited | Jul 2026 | ▲ New position | +0.02 Cr |
| J.B. Chemicals & Pharmaceuticals Lt | Jul 2026 | ▼ Complete exit | -0.01 Cr |
| Torrent Pharmaceuticals Limited | Jul 2026 | ▲ Increasing | +66,729 |
| Sun Pharmaceutical Industries Limited | Jul 2026 | ▼ Reducing | -46,248 |
| Biocon Limited | Jul 2026 | ▼ Reducing | -31,131 |
| Piramal Pharma Limited | Jul 2026 | ▼ Reducing | -27,185 |
| Dr. Reddy's Laboratories Limited | Jul 2026 | ▼ Reducing | -26,612 |
| Cipla Limited | Jul 2026 | ▼ Reducing | -24,573 |
| Laurus Labs Limited | Jul 2026 | ▼ Reducing | -16,974 |
| Aurobindo Pharma Limited | Jul 2026 | ▼ Reducing | -12,094 |
| Zydus Lifesciences Limited | Jul 2026 | ▼ Reducing | -10,945 |
| Lupin Limited | Jul 2026 | ▼ Reducing | -10,594 |
| Glenmark Pharmaceuticals Limited | Jul 2026 | ▼ Reducing | -6,576 |
| IPCA Laboratories Limited | Jul 2026 | ▼ Reducing | -6,095 |
| Divi's Laboratories Limited | Jul 2026 | ▼ Reducing | -5,544 |
| Mankind Pharma Limited | Jul 2026 | ▼ Reducing | -4,930 |
| Wockhardt Limited | Jul 2026 | ▼ Reducing | -3,593 |
| Gland Pharma Limited | Jul 2026 | ▼ Reducing | -3,464 |
| Alkem Laboratories Limited | Jul 2026 | ▼ Reducing | -2,544 |
| Ajanta Pharma Limited | Jul 2026 | ▼ Reducing | -1,898 |
| Abbott India Limited | Jul 2026 | ▼ Reducing | -222 |
| Sun Pharmaceutical Industries Limited | Jun 2026 | ▼ Reducing | -13,810 |
| Biocon Limited | Jun 2026 | ▼ Reducing | -9,827 |
| Aurobindo Pharma Limited | Jun 2026 | ▼ Reducing | -8,462 |
| Dr. Reddy's Laboratories Limited | Jun 2026 | ▼ Reducing | -7,682 |
| Cipla Limited | Jun 2026 | ▼ Reducing | -7,240 |
| Laurus Labs Limited | Jun 2026 | ▼ Reducing | -5,124 |
| Piramal Pharma Limited | Jun 2026 | ▼ Reducing | -4,077 |
| Zydus Lifesciences Limited | Jun 2026 | ▼ Reducing | -3,235 |
| Lupin Limited | Jun 2026 | ▼ Reducing | -2,656 |
| Glenmark Pharmaceuticals Limited | Jun 2026 | ▼ Reducing | -1,976 |
| IPCA Laboratories Limited | Jun 2026 | ▼ Reducing | -1,769 |
| Divi's Laboratories Limited | Jun 2026 | ▼ Reducing | -1,654 |
| Mankind Pharma Limited | Jun 2026 | ▼ Reducing | -1,367 |
| Wockhardt Limited | Jun 2026 | ▼ Reducing | -1,137 |
| J.B. Chemicals & Pharmaceuticals Lt | Jun 2026 | ▼ Reducing | -1,078 |
| Gland Pharma Limited | Jun 2026 | ▼ Reducing | -874 |
| Alkem Laboratories Limited | Jun 2026 | ▼ Reducing | -774 |
| Torrent Pharmaceuticals Limited | Jun 2026 | ▼ Reducing | -772 |
| Ajanta Pharma Limited | Jun 2026 | ▼ Reducing | -565 |
| Abbott India Limited | Jun 2026 | ▼ Reducing | -66 |
| Sun Pharmaceutical Industries Limited | May 2026 | ▲ Increasing | +0.02 Cr |
| Biocon Limited | May 2026 | ▲ Increasing | +0.01 Cr |
| Piramal Pharma Limited | May 2026 | ▲ Increasing | +0.01 Cr |
| Dr. Reddy's Laboratories Limited | May 2026 | ▲ Increasing | +0.01 Cr |
| Cipla Limited | May 2026 | ▲ Increasing | +95,210 |
| Laurus Labs Limited | May 2026 | ▲ Increasing | +65,926 |
| Aurobindo Pharma Limited | May 2026 | ▲ Increasing | +47,342 |
| Zydus Lifesciences Limited | May 2026 | ▲ Increasing | +42,311 |
| Lupin Limited | May 2026 | ▲ Increasing | +40,994 |
| Glenmark Pharmaceuticals Limited | May 2026 | ▲ Increasing | +25,440 |
| IPCA Laboratories Limited | May 2026 | ▲ Increasing | +23,606 |
| Divi's Laboratories Limited | May 2026 | ▲ Increasing | +21,473 |
| Mankind Pharma Limited | May 2026 | ▲ Increasing | +19,129 |
| Torrent Pharmaceuticals Limited | May 2026 | ▲ Increasing | +17,734 |
| Wockhardt Limited | May 2026 | ▲ Increasing | +14,108 |
| J.B. Chemicals & Pharmaceuticals Lt | May 2026 | ▲ Increasing | +13,802 |
| Gland Pharma Limited | May 2026 | ▲ Increasing | +13,424 |
| Alkem Laboratories Limited | May 2026 | ▲ Increasing | +10,005 |
| Ajanta Pharma Limited | May 2026 | ▲ Increasing | +7,105 |
Changes compare consecutive month-end disclosures for this portfolio only.